Genitourinary Radiology: Page 60

NRC report cites Philadelphia VA
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) cited the Philadelphia Veterans Affairs Medical Center (VAMC) for eight apparent violations of its regulations after an investigation into treatment errors in the VA's prostate cancer brachytherapy program between 2002 and 2008.
November 18, 2009
iCAD partners with AdMeTech
By AuntMinnie.com staff writers
Computer-aided detection (CAD) firm iCAD has formed a strategic partnership with AdMeTech Foundation, a nonprofit organization geared to fighting prostate cancer.
November 17, 2009
CMS to review RT for prostate cancer
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has scheduled a meeting of its Medicare Evidence Development and Coverage Advisory Committee on April 21, 2010, to consider the available evidence for radiation therapy (RT) for localized prostate cancer.
November 16, 2009
Perfusion CT protocols vary, but all require dose/quality tradeoffs
By Eric Barnes
The growing field of perfusion CT imaging has great potential to offer diagnostic information that other imaging methods cannot -- in tasks such as distinguishing cancer from vascular malformations, comparing perfusion patterns in two kidneys, or assessing blood flow to different parts of the brain.
November 12, 2009
2009 11 13 11 49 46 292 Rogalla thumb 11 09
RT alone can reduce PSA levels
By AuntMinnie.com staff writers
CHICAGO - Radiation therapy alone can reduce prostate-specific antigen (PSA) levels below detectable amounts in prostate cancer patients, researchers from Fox Chase Cancer Center in Philadelphia reported at the American Society for Radiation Oncology's annual meeting being held this week in Chicago.
November 3, 2009
ImaginAb licenses BZL technology
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has completed an agreement to license technology from BZL Biologics that could be used to develop a radiopharmaceutical for PET and SPECT prostate imaging.
October 12, 2009
Salvage rad therapy not toxic after prostatectomy
By AuntMinnie.com staff writers
A Mayo Clinic study of prostate cancer patients who received salvage radiation therapy following a radical prostatectomy has found that fewer than 15% experience late toxicities, and less than 1% experience serious complications five years after treatment, according to an article published online September 22 in Radiotherapy and Oncology.
September 30, 2009
Study: CyberKnife benefits prostate cancer patients
By AuntMinnie.com staff writers
Radiotherapy firm Accuray is touting the results of a study on early-stage prostate cancer patients treated with its CyberKnife radiosurgery system.
September 30, 2009
Rutgers, Siemens, Penn net MRI research grant
By AuntMinnie.com staff writers
The U.S. National Institutes of Health (NIH) has awarded a five-year, $3.4 million research grant to Siemens Healthcare, Rutgers University, and Penn Medicine to develop tools to improve the identification of prostate cancer using MRI.
September 22, 2009
Varian reports Australian milestone
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems said that the first radiotherapy treatments using its RapidArc technology have been performed in Australia.
September 16, 2009
Prostate brachytherapy side effects self-resolve
By AuntMinnie.com staff writers
Most men who have permanent prostate brachytherapy treatment for early-stage prostate cancer experience urinary side effects, but symptoms resolve for the majority of patients within one year following completion of radiation treatment, according to a report published in the September issue of Urology.
September 10, 2009
Algeta, Bayer join forces
By AuntMinnie.com staff writers
Therapeutic radiopharmaceutical developer Algeta has inked an $800 million agreement with Bayer for the development and commercialization of its Alpharadin alpha-emitting pharmaceutical for treating bone metastases.
September 7, 2009
Previous Page
Page 60 of 93
Next Page